HPV or human papillomavirus is the most common sexually transmitted infection affecting moist layers of skin that lines parts of the body such as the inside of the mouth, throat or genital areas. While it is usually harmless and can go away by itself, some types of HPV have been known to cause cervical cancer in women and oral cancer in men. These cancers, often affecting young healthy individuals, can be prevented through an HPV vaccine.
According to the CDC, 79 million Americans, most in their late teens and early twenties, are infected with HPV and about 14 million people become newly infected each year. Cancers often take years, even decades to develop after a person gets HPV. Globally, approximately 38,000 – 45,000 head and neck cancers are attributed to HPV each year.
Abut the Study
The purpose of this research study is to determine the efficacy and safety of a 3-dose HPV vaccine in males between the ages of 20- 45 years old. The vaccine aims to prevent HPV infection which are associated with oral cancer.
Study related care is provided to participants at no cost. Compensation may be available for time and travel up to $1,300 for those who qualify.
- Born-male between the ages of 20-45 years old
- In general good health
- Have had at least 1 sexual partner in your lifetime
- Have never recieved an HPV Vaccine (Gardasil or through a clinical trial)
- Planning on staying near the Rochester area within the next 5 years
- *Please note, other conditions may apply.